Trial Profile
An open-label, single-centered, non-randomized trial of inosine to assess its safety for patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs Inosine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 03 Aug 2016 Status changed from recruiting to completed.
- 19 Oct 2012 New trial record